Skip to main content
. 2017 Jun 8;12(6):e0177178. doi: 10.1371/journal.pone.0177178

Fig 5. Survival curves for revascularized patients divided into improvers versus non-improvers, and comparing with non ARVD control patients, adjusted for baseline age, co-morbidities, and GFR.

Fig 5